Alcohol Impairment: Clinical Trials

6 trials for Alcohol Impairment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting. 3 Not applicable, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Early Phase 11Completed 1
Phase 11Completed 1

Follow Alcohol Impairment: new trials by email Literature Review of Alcohol Impairment trials Research Report on Alcohol Impairment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurobehavioral Changes Following Spaceflight Stressors
Alcohol Administration, Sleep Deprivation, Control - Stressor, Individual, Alcohol Impairment
Not applicableRecruitingUniversity of Pennsylvania562026-08-042026-11-05
Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device
Alcoholic beverage - Alcohol Impairment, Nystagmus
CompletedGaize802024-03-212025-08-26
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations
Low Marijuana, Hash, THC, or Grass, High Marijuana, Hash, THC, or Grass, Placebo - Marijuana Impairment, Alcohol Impairment
Early Phase 1CompletedYale University412021-07-282025-07-01
Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving
Loss-framed text message, Gain-Framed text message - Alcohol Drinking, Alcohol Intoxication
Not applicableCompletedUniversity of Pennsylvania582017-12-212018-08-08
Family Based Prevention of Alcohol and Risky Sex for Older Teens
Smart Choices 4 Teens - Alcohol Drinking, Alcohol Intoxication
Not applicableCompletedPacific Institute for Research and Evaluation4112013-04-012023-07-27
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
Active Ethanol, Active Iomazenil, Placebo - Active Ethanol and Active Iomazenil, Active Ethanol and Placebo Iomazenil
Phase 1CompletedVA Office of Research and Development332012-12-142024-10-09

Narrower conditions

Alcoholic Intoxication (3)  ·  Alcohol Drinking (2)  ·  Driving Under the Influence (2)  ·  Alcohol Abstinence (1)  ·  Alcohol-Related Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Drinking Behavior (1)  ·  Marijuana Abuse (1)  ·  Nystagmus, Pathologic (1)  ·  Sexual Behavior (1)  ·  Sexual Harassment (1)  ·  Sleep Deprivation (1)  ·  Stress, Psychological (1)

Broader conditions

Mental Disorders (5)  ·  Behavior (4)  ·  Chemically-Induced Disorders (4)  ·  Substance-Related Disorders (4)  ·  Alcohol-Related Disorders (2)  ·  Criminal Behavior (2)  ·  Dangerous Behavior (2)  ·  Nervous System Diseases (2)  ·  Behavioral Symptoms (1)  ·  Cognition Disorders (1)  ·  Cranial Nerve Diseases (1)  ·  Drinking Behavior (1)  ·  Dyssomnias (1)  ·  Eye Diseases (1)  ·  Neurocognitive Disorders (1)

Interventions

Ethanol (3)  ·  Alcoholic Beverages (1)  ·  Dronabinol (1)  ·  Wakefulness (1)  ·  nabiximols (1)

Sponsors

University of Pennsylvania (2)  ·  Gaize (1)  ·  Pacific Institute for Research and Evaluation (1)  ·  VA Office of Research and Development (1)  ·  Yale University (1)

Countries

United States (6)

Top investigators

Brenda A Miller, Ph.D. (1)  ·  Deepak C D'Souza, MD MBBS (1)  ·  Godfrey Pearlson, M.D (1)  ·  Kit Delgado, MD, MS (1)  ·  Mathias Basner, MD, PhD, MScEpi (1)

Results publications

PMID 29172702, PMID 30640504, PMID 34128818